Drug recall · May 27, 2026
MG217 Multi-Symptom Treatment Cream & Skin Protectant recall
Why: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
- Lots / codes
Lot #: 1024088, Exp 11/30/2026
- Quantity
- 690 tubes
- Company
- Wisconsin Pharmacal Company, Jackson, WI
- Distribution
- USA Nationwide and Bahamas
- Initiated
- April 24, 2026 · Voluntary: Firm initiated
- Classified
- May 29, 2026
- Reported
- May 27, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Colloidal oatmeal
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.